National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee ...

The firm is evaluating its radiopharmaceutical imaging agent targeting PDGFRα, TLX300-CDx, in advanced or metastatic soft tissue sarcoma.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89Zr-olaratumab) in patients ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

The following is a summary of "Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a ...

Kalvin is a Grade 12 student at Avon View High School in Windsor.

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.

Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone. Adding chemotherapy to local therapy can improve survival in patients with ...

In March 2022, Gabor’s biopsy results were returned, which confirmed the presence of Ewing sarcoma ... the cancer began “attacking” Gabor’s bones. “His bones became very soft, he ...

You're talking maybe 10,000 to 12,000 new cases of soft tissue sarcoma per year, which is pretty rare in the ... Dr. Breelyn Wilky: Clearly, we all know that immune therapy has just changed cancer ...